Changcun Guo
- Cancer Research top 5%
- Hepatology top 5%
- Liver Diseases and Immunity 9
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 6
- Epigenetics and DNA Methylation 5
- Immunology top 10%
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 10
-
- Liver Disease Diagnosis and Treatment 15
-
- Inflammatory Bowel Disease 10
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Pediatric Hepatobiliary Diseases and Treatments 5
- Journals
- Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (3 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Changcun Guo
70 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 582
- Hepatology 173
- Molecular Biology 1.4k
- Immunology 357
- Oncology 451
Countries citing papers authored by Changcun Guo
This map shows the geographic impact of Changcun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changcun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changcun Guo more than expected).
Fields of papers citing papers by Changcun Guo
This network shows the impact of papers produced by Changcun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changcun Guo. The network helps show where Changcun Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Changcun Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 15 | |
| 8 | 2018 | 9 | |
| 9 | 2014 | 7 | |
| 10 | 2014 | 15 | |
| 11 | 2013 | 57 | |
| 12 | 2010 | 14 | |
| 13 | 2010 | 27 | |
| 14 | 2010 | 5 | |
| 15 | 2008 | 42 | |
| 16 | The Expression of Runx3 in Ulcerous Colitis | 2008 | 2 |
| 17 | 2008 | 30 | |
| 18 | 2007 | 23 | |
| 19 | 2006 | 53 | |
| 20 | 2003 | 20 |
About Changcun Guo
Changcun Guo is a scholar working on Hepatology, Cancer Research and Oncology, having authored 72 papers that have together received 2.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (15 papers), Drug Transport and Resistance Mechanisms (10 papers), Inflammatory Bowel Disease (10 papers), Liver Diseases and Immunity (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (6 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (582 citations), Hepatology (173 citations) and Molecular Biology (1.4k citations). Changcun Guo has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Daiming Fan, Kaichun Wu, Yongquan Shi, Li Sun, Zheyi Han, Yanglin Pan, Taidong Qiao, Yongzhan Nie, Hai Yan and John Beckly. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.